COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS Read more about COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS US Application 63/337,296Filed on 2022-05-02
Neoantigen T Cell Therapy With Neoantigen Vaccination As A Combination Immunotherapy Against Cancer Read more about Neoantigen T Cell Therapy With Neoantigen Vaccination As A Combination Immunotherapy Against Cancer US Application 63/295,762Filed on 2021-12-31
CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF Read more about CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF US Application 63/310,456Filed on 2022-02-15
ANTI-MESOTHELIN POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS Read more about ANTI-MESOTHELIN POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS US Application 63/290,761Filed on 2021-12-17
Anti-Viral Compositions And Methods Of Making And Using Read more about Anti-Viral Compositions And Methods Of Making And Using US Application 62/898,383Filed on 2019-09-10
Q-Griffithsin Nasal Spray Read more about Q-Griffithsin Nasal Spray US Application 63/070,375Filed on 2020-08-26
Compositions And Methods For Prevention Of Coronavirus Infection Read more about Compositions And Methods For Prevention Of Coronavirus Infection US Application 63/026,375Filed on 2020-05-18
METHODS FOR TREATING CANCERS WITH CYTOPLASMIC EXPORTIN 7 (XPO7) EXPRESSION WITH TIVOZANIB Read more about METHODS FOR TREATING CANCERS WITH CYTOPLASMIC EXPORTIN 7 (XPO7) EXPRESSION WITH TIVOZANIB US Application 63/283,406Filed on 2021-11-26
COMPOSITIONS AND METHODS FOR TREATING CANCER Read more about COMPOSITIONS AND METHODS FOR TREATING CANCER US Application 63/124,231Filed on 2020-12-11
HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION Read more about HLA-A3-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US Application 63/284,884Filed on 2021-12-01